药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cinolazepam
Tepoxalin
The risk or severity of gastrointestinal irritation can be increased when Tepoxalin is combined with Hydrocortisone butyrate.
Cinolazepam
Azosemide
The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Azosemide.
Cinolazepam
Piretanide
The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Piretanide.
Cinolazepam
Aluminium phosphate
The bioavailability of Hydrocortisone butyrate can be decreased when combined with Aluminium phosphate.
Cinolazepam
Calcium silicate
The bioavailability of Hydrocortisone butyrate can be decreased when combined with Calcium silicate.
Cinolazepam
Aloglutamol
The bioavailability of Hydrocortisone butyrate can be decreased when combined with Aloglutamol.
Cinolazepam
Aluminium glycinate
The bioavailability of Hydrocortisone butyrate can be decreased when combined with Aluminium glycinate.
Cinolazepam
Almasilate
The bioavailability of Hydrocortisone butyrate can be decreased when combined with Almasilate.
Cinolazepam
Magnesium peroxide
The bioavailability of Hydrocortisone butyrate can be decreased when combined with Magnesium peroxide.
Cinolazepam
Hydrotalcite
The bioavailability of Hydrocortisone butyrate can be decreased when combined with Hydrotalcite.
Cinolazepam
Aluminium acetoacetate
The bioavailability of Hydrocortisone butyrate can be decreased when combined with Aluminium acetoacetate.
Cinolazepam
Magnesium silicate
The bioavailability of Hydrocortisone butyrate can be decreased when combined with Magnesium silicate.
Cinolazepam
Magnesium trisilicate
The bioavailability of Hydrocortisone butyrate can be decreased when combined with Magnesium trisilicate.
Cinolazepam
Magnesium hydroxide
The bioavailability of Hydrocortisone butyrate can be decreased when combined with Magnesium hydroxide.
Cinolazepam
Magaldrate
The bioavailability of Hydrocortisone butyrate can be decreased when combined with Magaldrate.
Cinolazepam
Calcium carbonate
The bioavailability of Hydrocortisone butyrate can be decreased when combined with Calcium carbonate.
Cinolazepam
Aluminum hydroxide
The bioavailability of Hydrocortisone butyrate can be decreased when combined with Aluminum hydroxide.
Cinolazepam
GLPG-0492
The risk or severity of fluid retention can be increased when Hydrocortisone butyrate is combined with GLPG-0492.
Cinolazepam
Stanozolol
The risk or severity of fluid retention can be increased when Hydrocortisone butyrate is combined with Stanozolol.
Cinolazepam
Oxymetholone
The risk or severity of fluid retention can be increased when Hydrocortisone butyrate is combined with Oxymetholone.